Form 8-K - Current report:
SEC Accession No. 0001104659-24-063008
Filing Date
2024-05-17
Accepted
2024-05-17 16:15:27
Documents
16
Period of Report
2024-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2414822d1_8k.htm   iXBRL 8-K 41044
2 EXHIBIT 4.1 tm2414822d1_ex4-1.htm EX-4.1 1263471
3 EXHIBIT 4.3 tm2414822d1_ex4-3.htm EX-4.3 1112195
4 EXHIBIT 10.1 tm2414822d1_ex10-1.htm EX-10.1 1542833
  Complete submission text file 0001104659-24-063008.txt   4917765

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ogn-20240517.xsd EX-101.SCH 3009
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20240517_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20240517_pre.xml EX-101.PRE 22356
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2414822d1_8k_htm.xml XML 3672
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 24959871
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)